Kim Lorenz

1 month ago | medrxiv.org | Junghyun Lim |Marijana Vujkovic |Michael Levin |Kim Lorenz

The authors have declared no competing interest. CTSA award number UL1TR001878, NHGRI under award 5T32HG009495, Doris Duke Foundation (Award 2023-0224), US Department of Veterans Affairs Biomedical Research and Development Award IK2-BX006551, NHLBI under the award number F30HL172382, NIH/NIDDK (UM1DK126194)I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Nov 4, 2024 | blog.prif.org | Kim Lorenz

The upcoming U.S. elections signal a potential shift in U.S.-Korean relations. While Kamala Harris would likely continue President Biden’s focus on sanctions and deterrence, Donald Trump might just as easily revive diplomatic talks as cause another flare-up of tensions on the Korean peninsula. Meanwhile, South Korea is concerned about U.S. security commitments and currently debating whether to pursue its own nuclear deterrent.

Feb 19, 2024 | nature.com | Konstantinos Hatzikotoulas |Henry Taylor |Xianyong Yin |Kim Lorenz |Mark McCarthy |Anubha Mahajan | +6 more

AbstractType 2 diabetes (T2D) is a heterogeneous disease that develops through diverse pathophysiological processes1,2 and molecular mechanisms that are often specific to cell type3,4. Here, to characterize the genetic contribution to these processes across ancestry groups, we aggregate genome-wide association study data from 2,535,601 individuals (39.7% not of European ancestry), including 428,452 cases of T2D.